ETR
68
-3
FDX
54
14
MS
80
-3
MMM
42
5
FTI
78
-3
SIG
47
-2
ACN
70
5
LOW
58
2
ABT
57
-5
HSY
43
3
AON
60
2
DE
36
-2
DVA
72
-3
DUK
50
-2
DOW
30
2
CMI
67
4
PFG
50
-2
DLTR
40
4
KO
44
2
OMC
64
-2
ETR
68
-3
FDX
54
14
MS
80
-3
MMM
42
5
FTI
78
-3
SIG
47
-2
ACN
70
5
LOW
58
2
ABT
57
-5
HSY
43
3
AON
60
2
DE
36
-2
DVA
72
-3
DUK
50
-2
DOW
30
2
CMI
67
4
PFG
50
-2
DLTR
40
4
KO
44
2
OMC
64
-2
Financhill
Back

Range Cancer Therapeutics ETF Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Sell
44

CNCR
Range Cancer Therapeutics ETF

Last Price:
15.24
Seasonality Move:
1.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Range Cancer Therapeutics ETF Price Quote

$15.24
+0.44 (+0.98%)
(Updated: November 14, 2024 at 5:11 AM ET)

Range Cancer Therapeutics ETF Key Stats

Sell
44
Range Cancer Therapeutics ETF (CNCR) is a Sell
Day range:
$14.94 - $15.34
52-week range:
$10.06 - $17.96
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
1.2K
Avg. volume:
3.3K
1-year change:
52.11%
Market cap:
$0
Revenue:
$0
EPS:
$0

How Much Does Range Cancer Therapeutics ETF Make?

Data Unavailable

Is Range Cancer Therapeutics ETF Growing As A Company?

Data Unavailable

Range Cancer Therapeutics ETF Stock Price Performance

What Is Range Cancer Therapeutics ETF 52-Week High & Low?

Range Cancer Therapeutics ETF Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Range Cancer Therapeutics ETF?

Data Unavailable

Is Range Cancer Therapeutics ETF Cash Flow Positive?

Data Unavailable

Range Cancer Therapeutics ETF Return On Invested Capital

Data Unavailable

Range Cancer Therapeutics ETF Earnings Date & Stock Price

Range Cancer Therapeutics ETF Competitors

  • Who Are Range Cancer Therapeutics ETF's Competitors?
    Below is a list of companies who compete with Range Cancer Therapeutics ETF or are related in some way:
    • Virtus LifeSci Biotech Clinical Trls ETF (BBC)
    • Virtus LifeSci Biotech Products ETF (BBP)
    • First Trust Nasdaq Pharmaceuticals ETF (FTXH)
    • Invesco Nasdaq Biotechnology ETF (IBBQ)
    • SPDR® S&P Health Care Services ETF (XHS)

Range Cancer Therapeutics ETF Dividend Yield

Range Cancer Therapeutics ETF Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable